Literature DB >> 4598805

Microvascular protection with calcium dobesilate (Doxium) in diabetic retinopathy.

H Freyler.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4598805     DOI: 10.1159/000307064

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


× No keyword cloud information.
  5 in total

1.  Effect of calcium dobesilate on the blood-retinal barrier in early diabetic retinopathy.

Authors:  E B Leite; M C Mota; J R de Abreu; J G Cunha-Vaz
Journal:  Int Ophthalmol       Date:  1990-03       Impact factor: 2.031

2.  Effect of calcium dobesilate on progression of early diabetic retinopathy: a randomised double-blind study.

Authors:  Maria L Ribeiro; Andras I Seres; Angela M Carneiro; Michael Stur; Alain Zourdani; Patricia Caillon; José G Cunha-Vaz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-12       Impact factor: 3.117

3.  The value of calcium dobesilate in the treatment of diabetic retinopathy. A controlled clinical trial.

Authors:  H W Larsen; E Sander; R Hoppe
Journal:  Diabetologia       Date:  1977-04       Impact factor: 10.122

4.  DRDB: A Machine Learning Platform to Predict Chemical-Protein Interactions towards Diabetic Retinopathy.

Authors:  Yu Wei; Ruili Zhang; Xiaoqiang Li; Zhonglin Li; Kaimin Guo; Shanshan Li; Li Yan; Qian Zhao; Baijian Qu; Wenjia Wang; Shuiping Zhou; He Sun; Jianping Lin; Yunhui Hu
Journal:  Oxid Med Cell Longev       Date:  2022-07-20       Impact factor: 7.310

5.  Calcium dobesilate reduces endothelin-1 and high-sensitivity C-reactive protein serum levels in patients with diabetic retinopathy.

Authors:  Alireza Javadzadeh; Amir Ghorbanihaghjo; Farzad Hami Adl; Dima Andalib; Hassan Khojasteh-Jafari; Kamyar Ghabili
Journal:  Mol Vis       Date:  2013-01-10       Impact factor: 2.367

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.